United States · 
Who invested in Sermonix Pharmaceuticals?
Sermonix Pharmaceuticals's investors include Perceptive Advisors.
United States · Series A startup
Who invested in Sermonix Pharmaceuticals
Funding summaryUpdated 26 Oct 2026
$40Mraised across 1 round since 2021, from 1 source
- Latest round
- Series A, $40MNov 2021
- Investors
- 1
The rounds
- Nov 2021
Founders and team
From the SEC filings it signed: 7 on the team.
- Anthony WildExecutive Officer, Directori
- Barry KommExecutive Officeri
- David PortmanExecutive Officer, Director, Promoteri
- Elizabeth AttiasExecutive Officeri
- Miriam PortmanExecutive Officer, Promoteri
- Paul PlourdeExecutive Officeri
- Simon JenkinsExecutive Officeri
On the board, as filediElizabeth GarnerMichael FriedmanRichard De SchutterThomas Pfisterer
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Sermonix Pharmaceuticals
How much has Sermonix Pharmaceuticals raised?
Sermonix Pharmaceuticals has raised $40M across 1 round since 2021.
When did Sermonix Pharmaceuticals last raise?
Sermonix Pharmaceuticals's most recent round was a Series A of $40M in Nov 2021.
What was Sermonix Pharmaceuticals's biggest round?
Its most recent round, $40M in Nov 2021, is also its largest on record.
Who backed Sermonix Pharmaceuticals first?
Sermonix Pharmaceuticals's first round on record, in Nov 2021, was backed by Perceptive Advisors.
What stage is Sermonix Pharmaceuticals at?
Sermonix Pharmaceuticals's latest named round is a Series A, in Nov 2021.
Where is Sermonix Pharmaceuticals based?
Sermonix Pharmaceuticals is based in the United States.
Companies like Sermonix Pharmaceuticals
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.